206 related articles for article (PubMed ID: 34696366)
1. IFNα and β Mediated JCPyV Suppression through C/EBPβ-LIP Isoform.
May D; Bellizzi A; Kassa W; Cipriaso JM; Caocci M; Wollebo HS
Viruses; 2021 Sep; 13(10):. PubMed ID: 34696366
[TBL] [Abstract][Full Text] [Related]
2. Modulation of JC virus transcription by C/EBPbeta.
Romagnoli L; Wollebo HS; Deshmane SL; Mukerjee R; Del Valle L; Safak M; Khalili K; White MK
Virus Res; 2009 Dec; 146(1-2):97-106. PubMed ID: 19747512
[TBL] [Abstract][Full Text] [Related]
3. High expression of JC polyomavirus-encoded microRNAs in progressive multifocal leukoencephalopathy tissues and its repressive role in virus replication.
Takahashi K; Sato Y; Sekizuka T; Kuroda M; Suzuki T; Hasegawa H; Katano H
PLoS Pathog; 2020 Apr; 16(4):e1008523. PubMed ID: 32324824
[TBL] [Abstract][Full Text] [Related]
4. Human iPS cell-derived astrocytes support efficient replication of progressive multifocal leukoencephalopathy-type JC polyomavirus.
Shimbo E; Nukuzuma S; Tagawa YI
Biochem Biophys Res Commun; 2020 Dec; 533(4):983-987. PubMed ID: 33008586
[TBL] [Abstract][Full Text] [Related]
5. Establishment of COS-JC cells persistently producing archetype JC polyomavirus.
Nukuzuma S; Nukuzuma C; Kameoka M; Sugiura S; Nakamichi K; Tasaki T; Hidaka K; Takegami T
Microbiol Immunol; 2018 Aug; 62(8):524-530. PubMed ID: 29932215
[TBL] [Abstract][Full Text] [Related]
6. ERK Is a Critical Regulator of JC Polyomavirus Infection.
DuShane JK; Wilczek MP; Mayberry CL; Maginnis MS
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321332
[TBL] [Abstract][Full Text] [Related]
7. JC Polyomavirus Infection Reveals Delayed Progression of the Infectious Cycle in Normal Human Astrocytes.
Wilczek MP; DuShane JK; Armstrong FJ; Maginnis MS
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826993
[TBL] [Abstract][Full Text] [Related]
8. Degradation of polyomavirus JC T-antigen by stress involves the LIP isoform of C/EBP.
Bellizzi A; White MK; Wollebo HS
Cell Cycle; 2015; 14(13):2075-9. PubMed ID: 26017382
[TBL] [Abstract][Full Text] [Related]
9. Characterization of JC Polyomavirus Derived from COS-IMRb Cells.
Nukuzuma S; Nukuzuma C; Kameoka M; Sugiura S; Nakamichi K; Tasaki T; Hidaka K; Takegami T
Jpn J Infect Dis; 2021 Jan; 74(1):48-53. PubMed ID: 32741932
[TBL] [Abstract][Full Text] [Related]
10. JCPyV NCCR analysis in PML patients with different risk factors: exploring common rearrangements as essential changes for neuropathogenesis.
Ciardi MR; Zingaropoli MA; Iannetta M; Prezioso C; Perri V; Pasculli P; Lichtner M; d'Ettorre G; Altieri M; Conte A; Pietropaolo V; Mastroianni CM; Vullo V
Virol J; 2020 Feb; 17(1):23. PubMed ID: 32046748
[TBL] [Abstract][Full Text] [Related]
11. Progressive multifocal leukoencephalopathy-associated mutations in the JC polyomavirus capsid disrupt lactoseries tetrasaccharide c binding.
Maginnis MS; Ströh LJ; Gee GV; O'Hara BA; Derdowski A; Stehle T; Atwood WJ
mBio; 2013 Jun; 4(3):e00247-13. PubMed ID: 23760462
[TBL] [Abstract][Full Text] [Related]
12. COS-7 and SVGp12 Cellular Models to Study JCPyV Replication and MicroRNA Expression after Infection with Archetypal and Rearranged-NCCR Viral Strains.
Prezioso C; Passerini S; Limongi D; Palamara AT; Moens U; Pietropaolo V
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146876
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of JCPyV infection mediated by targeted viral genome editing using CRISPR/Cas9.
Chou YY; Krupp A; Kaynor C; Gaudin R; Ma M; Cahir-McFarland E; Kirchhausen T
Sci Rep; 2016 Nov; 6():36921. PubMed ID: 27841295
[TBL] [Abstract][Full Text] [Related]
14. JC Polyomavirus Entry by Clathrin-Mediated Endocytosis Is Driven by β-Arrestin.
Mayberry CL; Soucy AN; Lajoie CR; DuShane JK; Maginnis MS
J Virol; 2019 Apr; 93(8):. PubMed ID: 30700597
[TBL] [Abstract][Full Text] [Related]
15. CPT11 prevents virus replication in JCI cells persistently infected with JC polyomavirus.
Nukuzuma S; Nukuzuma C; Kameoka M; Sugiura S; Nakamichi K; Tasaki T; Takegami T
Microbiol Immunol; 2017 Jun; 61(6):232-238. PubMed ID: 28463406
[TBL] [Abstract][Full Text] [Related]
16. Cooperative roles of NF-κB and NFAT4 in polyomavirus JC regulation at the KB control element.
Wollebo HS; Melis S; Khalili K; Safak M; White MK
Virology; 2012 Oct; 432(1):146-54. PubMed ID: 22749879
[TBL] [Abstract][Full Text] [Related]
17. Suppressive effect of topoisomerase inhibitors on JC polyomavirus propagation in human neuroblastoma cells.
Nukuzuma S; Nakamichi K; Kameoka M; Sugiura S; Nukuzuma C; Tasaki T; Takegami T
Microbiol Immunol; 2016 Apr; 60(4):253-60. PubMed ID: 26935240
[TBL] [Abstract][Full Text] [Related]
18. COS-7 cells are a cellular model to monitor polyomavirus JC miR-J1-5p expression.
Agostini S; Mancuso R; Costa AS; Guerini FR; Clerici M
Mol Biol Rep; 2020 Nov; 47(11):9201-9205. PubMed ID: 33085050
[TBL] [Abstract][Full Text] [Related]
19. Single-Molecule Sequencing Revealing the Presence of Distinct JC Polyomavirus Populations in Patients With Progressive Multifocal Leukoencephalopathy.
Seppälä H; Virtanen E; Saarela M; Laine P; Paulín L; Mannonen L; Auvinen P; Auvinen E
J Infect Dis; 2017 Mar; 215(6):889-895. PubMed ID: 28453853
[TBL] [Abstract][Full Text] [Related]
20. Risk Assessment of Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patients during 1 Year of Ocrelizumab Treatment.
Prezioso C; Grimaldi A; Landi D; Nicoletti CG; Brazzini G; Piacentini F; Passerini S; Limongi D; Ciotti M; Palamara AT; Marfia GA; Pietropaolo V
Viruses; 2021 Aug; 13(9):. PubMed ID: 34578264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]